The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
S. J. Ritch, A. S. Noman, A. A. Goyeneche, C. M. Telleria
This study compares metastatic abilities of high-grade serous ovarian cancer cells across disease stages in 2D and 3D assays and shows mifepristone inhibits these behaviors in all models.
bioRxiv · May 7, 2022 · PreprintCancer Biology